secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K/A
Filed at:   2021-08-30T23:59:59+00:00
Accession:  0000010795-21-000066
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BD appoints Christopher DelOrefice as CFO; Reidy to retire after Diabetes Care spin-off
--------------------------------------------------------------------------------

- Christopher DelOrefice elected EVP and CFO effective September 6, 2021.
- Christopher Reidy remains EVP and CAO until Dec 31, 2021, then focuses on Diabetes Care spin-off until March 31, 2022.
- Reidy's base salary reduced to $441,859 from Jan 2022; bonus target cut from 90% to 70% of salary.
- Reidy receives reduced equity award of $700,000 instead of $3.3 million in November 2021.
- Diabetes Care spin-off subject to Board approval, regulatory clearances, and effective Form 10.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000001079521000066/0000010795-21-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000001079521000066/bdx-20210802.htm
  HTML page:      https://secwatch.observer/filing/0000010795-21-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer